Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review
Nutrients · 03.03.2026 · 18 (5) · 826
DOI: 10.3390/nu18050826 ↗Kurz gefasst
Scoping Review in der Zeitschrift Nutrients, online erschienen am 03.03.2026. Verfasst von Kadriye Elif İmre und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Kastamonu University, 37150 Kastamonu, Turkey. Hauptthemen laut MEDLINE: Propolis, Obesity, Metabolic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Obesity and related metabolic disorders, including insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease, represent major global health challenges. Growing interest in complementary strategies has brought propolis, a resinous bee-derived product rich in phenolic and flavonoid compounds, into focus. This scoping review aimed to map and synthesize available in vitro, in vivo, and clinical evidence regarding the metabolic effects of whole propolis preparations and propolis-derived bioactive compounds in obesity-related contexts.
Methods
The review was conducted in accordance with the PRISMA-ScR framework and included experimental and human studies evaluating adipogenesis, lipid and glucose metabolism, oxidative stress, inflammatory signaling, non-alcoholic fatty liver disease-related outcomes, and gut microbiota modulation.
Results
Across preclinical models, propolis preparations have been associated with modulation of antioxidant defenses, attenuation of inflammatory signaling, regulation of adipogenic transcriptional programs, and alterations in gut microbiota composition and barrier integrity. Clinical evidence suggests modest improvements in selected metabolic and inflammatory biomarkers; however, effects on body weight and adiposity remain inconsistent. Interpretation is limited by heterogeneity in propolis type, extraction method, chemical standardization, dosing strategies, and study design.
Conclusions
Overall, current evidence indicates that propolis may influence obesity-related metabolic pathways, primarily at the level of biomarker modulation. Nevertheless, mechanistic causality and long-term clinical efficacy require confirmation through well-designed, adequately powered, and chemically standardized trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Dietetics, Kastamonu University, 37150 Kastamonu, Turkey.
- Department of Nutrition and Dietetics, Hacettepe University, 06100 Ankara, Turkey.
ORCID-Profile: Kadriye Elif İmre, Aslı Akyol
Zitieren
APA
İmre, K. E., & Akyol, A. (2026). Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review. Nutrients, 18(5), 826. https://doi.org/10.3390/nu18050826
Vancouver
İmre KE, Akyol A. Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review. Nutrients. 2026;18(5):826. doi:10.3390/nu18050826
BibTeX
@article{mre2026,
author = {İmre, Kadriye Elif and Akyol, Aslı},
title = {Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {5},
pages = {826},
doi = {10.3390/nu18050826}
}
EUVIMED